RT Journal Article
SR Electronic
T1 Social distancing strategies for curbing the COVID-19 epidemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.22.20041079
DO 10.1101/2020.03.22.20041079
A1 Stephen Kissler
A1 Christine Tedijanto
A1 Marc Lipsitch
A1 Yonatan H. Grad
YR 2020
UL http://medrxiv.org/content/early/2020/03/24/2020.03.22.20041079.abstract
AB The SARS-CoV-2 pandemic is straining healthcare resources worldwide, prompting social distancing measures to reduce transmission intensity. The amount of social distancing needed to curb the SARS-CoV-2 epidemic in the context of seasonally varying transmission remains unclear. Using a mathematical model, we assessed that one-time interventions will be insufficient to maintain COVID-19 prevalence within the critical care capacity of the United States. Seasonal variation in transmission will facilitate epidemic control during the summer months but could lead to an intense resurgence in the autumn. Intermittent distancing measures can maintain control of the epidemic, but without other interventions, these measures may be necessary into 2022. Increasing critical care capacity could reduce the duration of the SARS-CoV-2 epidemic while ensuring that critically ill patients receive appropriate care.Summary One-time distancing results in a fall COVID-19 peak. Intermittent efforts require greater hospital capacity and surveillance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe manuscript includes no data.